Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Breen

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Neuro-Oncology|February 1, 2020
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade gliomaWilliam G Breen, S Keith Anderson, Xiomara W Carrero, et al.
Practical Radiation Oncology|December 20, 2021
Factors Associated With Acute Toxicity in Pediatric Patients Treated With Proton Radiation Therapy: A Report From the Pediatric Proton Consortium RegistryWilliam G Breen, Arnold C Paulino, William F Hartsell, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite PracticeMatthew R Buras, William G Breen, Nadia N Laack, et al.
Neuro-Oncology|June 28, 2025
Final Report on NCCTG N0877 (Alliance): A Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy with or without Dasatinib for GlioblastomaWilliam G Breen, J G Dixon, S K Anderson, et al.
Chinese Clinical Oncology|August 13, 2023
The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancerJulie R Bloom, Alexandra Hotca, Daniel R Cherry, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 17, 2025
Tumor treating fields utilization and efficacy for glioblastoma at a large multicenter academic practiceDavid J Crompton, Shelby Kern, Aaron Bogan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2021
Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicityWilliam G Breen, Elizabeth B Jeans, Kimberly R Gergelis, et al.
Journal of Hematology & Oncology|March 29, 2022
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CTWilliam G Breen, Matthew A Hathcock, Jason R Young, et al.
Clinical and Translational Radiation Oncology|March 18, 2021
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experienceKrishan R Jethwa, Courtney N Day, Harigopal Sandhyavenu, et al.
Blood Cancer Journal|August 22, 2022
Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapyKelsey M Frechette, Scott C Lester, Kekoa Taparra, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Neuro-Oncology|February 1, 2020
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade gliomaWilliam G Breen, S Keith Anderson, Xiomara W Carrero, et al.
Practical Radiation Oncology|December 20, 2021
Factors Associated With Acute Toxicity in Pediatric Patients Treated With Proton Radiation Therapy: A Report From the Pediatric Proton Consortium RegistryWilliam G Breen, Arnold C Paulino, William F Hartsell, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite PracticeMatthew R Buras, William G Breen, Nadia N Laack, et al.
Neuro-Oncology|June 28, 2025
Final Report on NCCTG N0877 (Alliance): A Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy with or without Dasatinib for GlioblastomaWilliam G Breen, J G Dixon, S K Anderson, et al.
Chinese Clinical Oncology|August 13, 2023
The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancerJulie R Bloom, Alexandra Hotca, Daniel R Cherry, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 17, 2025
Tumor treating fields utilization and efficacy for glioblastoma at a large multicenter academic practiceDavid J Crompton, Shelby Kern, Aaron Bogan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2021
Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicityWilliam G Breen, Elizabeth B Jeans, Kimberly R Gergelis, et al.
Journal of Hematology & Oncology|March 29, 2022
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CTWilliam G Breen, Matthew A Hathcock, Jason R Young, et al.
Clinical and Translational Radiation Oncology|March 18, 2021
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experienceKrishan R Jethwa, Courtney N Day, Harigopal Sandhyavenu, et al.
Blood Cancer Journal|August 22, 2022
Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapyKelsey M Frechette, Scott C Lester, Kekoa Taparra, et al.
Pageof 10